Diagnostic accuracy of parkinsonism syndromes by general neurologists
- PMID: 24816002
- DOI: 10.1016/j.parkreldis.2014.04.019
Diagnostic accuracy of parkinsonism syndromes by general neurologists
Abstract
Introduction: Movement disorder specialists can achieve a high level of accuracy when clinically diagnosing parkinsonism syndromes. However, data about the diagnostic accuracy among general neurologists is limited.
Objectives: This study investigated the recent diagnostic accuracy of parkinsonism syndromes by general neurologists.
Methods: A retrospective examination of 1362 post-mortem cases diagnosed in the years 2000-2012 by neuropathologists was performed. Out of these cases, we identified 111 patients who received a clinical parkinsonism diagnosis during life and 122 patients who received a neuropathological diagnosis of a parkinsonism syndrome post-mortem including 11 incidental cases.
Results: Fifty-eight (75.3%) of the 77 patients who had received clinical Parkinson's disease (PD) diagnoses were confirmed after the neuropathological examination. The sensitivity of the clinical diagnosis for idiopathic Parkinson's disease (PD) was 89.2% and the specificity was 57.8%. The corresponding numbers for progressive supranuclear palsy (PSP) were 52.9% and 100%, and for multiple system atrophy (MSA) were 64.3% and 99.0%, respectively.
Conclusions: Parkinson's disease is heavily overdiagnosed by general neurologists, whereas parkinsonism plus syndromes are underdiagnosed. Despite improvements in the diagnostic methods during recent decades and the development of diagnostic clinical criteria for parkinsonian syndromes, the diagnostic accuracy of Parkinson's disease remains relatively low, and 1/4 of diagnoses are incorrect.
Keywords: Clinicopathological study; Multiple system atrophy; Neuropathology; Parkinson's disease; Progressive supranuclear palsy.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.Mov Disord. 2010 Feb 15;25(3):341-8. doi: 10.1002/mds.22987. Mov Disord. 2010. PMID: 20108376
-
Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.Mov Disord. 1998 Jan;13(1):70-7. doi: 10.1002/mds.870130116. Mov Disord. 1998. PMID: 9452329
-
The interrelationship between non-motor symptoms in Atypical Parkinsonism.J Neurol Sci. 2013 Apr 15;327(1-2):15-21. doi: 10.1016/j.jns.2013.01.034. Epub 2013 Feb 18. J Neurol Sci. 2013. PMID: 23428208
-
Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.Rev Neurol (Paris). 2010 Oct;166(10):829-33. doi: 10.1016/j.neurol.2010.07.004. Epub 2010 Sep 1. Rev Neurol (Paris). 2010. PMID: 20813385 Review.
-
[Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: review of the literature].Rev Neurol (Paris). 2000;156 Suppl 2 Pt 2:14-22. Rev Neurol (Paris). 2000. PMID: 10916032 Review. French.
Cited by
-
Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy.Acta Neuropathol Commun. 2018 Jul 23;6(1):65. doi: 10.1186/s40478-018-0568-3. Acta Neuropathol Commun. 2018. PMID: 30037345 Free PMC article.
-
Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson's disease and controls.Neuroimage Clin. 2023;39:103479. doi: 10.1016/j.nicl.2023.103479. Epub 2023 Jul 22. Neuroimage Clin. 2023. PMID: 37494758 Free PMC article.
-
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.Expert Rev Mol Diagn. 2020 Apr;20(4):421-441. doi: 10.1080/14737159.2020.1731306. Epub 2020 Feb 27. Expert Rev Mol Diagn. 2020. PMID: 32066283 Free PMC article. Review.
-
Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.Acta Neuropathol Commun. 2020 Mar 26;8(1):39. doi: 10.1186/s40478-020-00914-9. Acta Neuropathol Commun. 2020. PMID: 32216828 Free PMC article.
-
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.Acta Neuropathol. 2021 Sep;142(3):495-511. doi: 10.1007/s00401-021-02324-0. Epub 2021 May 15. Acta Neuropathol. 2021. PMID: 33991233 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous